AAH07716.3
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
Succinate-CoA ligase, GDP-forming, beta subunit
NCBI Official Synonym Full Names
succinate-CoA ligase, GDP-forming, beta subunit
NCBI Official Synonym Symbols
NCBI Protein Information
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial; succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial; SCS-betaG; succinyl-CoA synthetase beta-G chain; succinyl-CoA synthetase, beta-G chain; GTP-specific succinyl-CoA synthetase beta subunit; GTP-specific succinyl-CoA synthetase subunit beta; succinyl-CoA ligase, GDP-forming, beta chain, mitochondrial
UniProt Protein Name
Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial
UniProt Synonym Protein Names
GTP-specific succinyl-CoA synthetase subunit beta; Succinyl-CoA synthetase beta-G chain; SCS-betaG
UniProt Synonym Gene Names
UniProt Entry Name
SUCB2_HUMAN
NCBI Summary for SUCLG2
This gene encodes a GTP-specific beta subunit of succinyl-CoA synthetase. Succinyl-CoA synthetase catalyzes the reversible reaction involving the formation of succinyl-CoA and succinate. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 5 and 12. [provided by RefSeq, Apr 2010]
UniProt Comments for SUCLG2
SUCLG2: Catalyzes the GTP-dependent ligation of succinate and CoA to form succinyl-CoA. Belongs to the succinate/malate CoA ligase beta subunit family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: EC 6.2.1.4; Mitochondrial; Carbohydrate Metabolism - citrate (TCA) cycle; Ligase; Carbohydrate Metabolism - propanoate
Chromosomal Location of Human Ortholog: 3p14.1
Cellular Component: mitochondrion; mitochondrial matrix; plasma membrane
Molecular Function: succinate-CoA ligase (GDP-forming) activity; GDP binding; GTP binding; protein heterodimerization activity; ATP binding
Biological Process: cellular metabolic process; succinate metabolic process; tricarboxylic acid cycle; succinyl-CoA metabolic process
Research Articles on SUCLG2
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Products associated with anti-SUCLG2 antibody
Pathways associated with anti-SUCLG2 antibody
Products by Pathway |
Pathway Diagram |
Carbon Metabolism Pathway antibodies |
Carbon Metabolism Pathway Diagram |
Carbon Metabolism Pathway antibodies |
Carbon Metabolism Pathway Diagram |
Citrate Cycle (TCA Cycle) Pathway antibodies |
Citrate Cycle (TCA Cycle) Pathway Diagram |
Citrate Cycle (TCA Cycle) Pathway antibodies |
Citrate Cycle (TCA Cycle) Pathway Diagram |
Citrate Cycle (TCA Cycle, Krebs Cycle) Pathway antibodies |
Citrate Cycle (TCA Cycle, Krebs Cycle) Pathway Diagram |
Citrate Cycle (TCA Cycle, Krebs Cycle) Pathway antibodies |
Citrate Cycle (TCA Cycle, Krebs Cycle) Pathway Diagram |
Citrate Cycle, Second Carbon Oxidation, 2-oxoglutarate => Oxaloacetate Pathway antibodies |
Citrate Cycle, Second Carbon Oxidation, 2-oxoglutarate => Oxaloacetate Pathway Diagram |
Citrate Cycle, Second Carbon Oxidation, 2-oxoglutarate => Oxaloacetate Pathway antibodies |
Citrate Cycle, Second Carbon Oxidation, 2-oxoglutarate => Oxaloacetate Pathway Diagram |
Citric Acid Cycle (TCA Cycle) Pathway antibodies |
Citric Acid Cycle (TCA Cycle) Pathway Diagram |
Metabolic Pathways antibodies |
Metabolic Pathways Diagram |
Diseases associated with anti-SUCLG2 antibody
Organs/Tissues associated with anti-SUCLG2 antibody
|